SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001718108-22-000022
Filing Date
2022-11-02
Accepted
2022-11-02 06:35:36
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-20220930.htm   iXBRL 10-Q 1365990
2 EX-31.1 surf-09302022xexx311.htm EX-31.1 10216
3 EX-31.2 surf-09302022xexx312.htm EX-31.2 10016
4 EX-32.1 surf-09302022xexx321.htm EX-32.1 5155
5 EX-32.2 surf-09302022xexx322.htm EX-32.2 4863
  Complete submission text file 0001718108-22-000022.txt   6551929

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20220930.xsd EX-101.SCH 44672
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT surf-20220930_cal.xml EX-101.CAL 52005
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT surf-20220930_def.xml EX-101.DEF 259127
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20220930_lab.xml EX-101.LAB 584333
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20220930_pre.xml EX-101.PRE 394641
62 EXTRACTED XBRL INSTANCE DOCUMENT surf-20220930_htm.xml XML 1033538
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 221352219
SIC: 2836 Biological Products, (No Diagnostic Substances)